nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—Cerebrovascular accident—Methotrexate—rheumatoid arthritis	0.00094	0.00222	CcSEcCtD
Loxapine—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.000926	0.00219	CcSEcCtD
Loxapine—Agitation—Cyclosporine—rheumatoid arthritis	0.000922	0.00218	CcSEcCtD
Loxapine—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000916	0.00217	CcSEcCtD
Loxapine—Fatigue—Leflunomide—rheumatoid arthritis	0.000915	0.00216	CcSEcCtD
Loxapine—Constipation—Leflunomide—rheumatoid arthritis	0.000908	0.00215	CcSEcCtD
Loxapine—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000898	0.00212	CcSEcCtD
Loxapine—Cough—Cyclosporine—rheumatoid arthritis	0.000876	0.00207	CcSEcCtD
Loxapine—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.000875	0.00207	CcSEcCtD
Loxapine—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000873	0.00206	CcSEcCtD
Loxapine—Convulsion—Cyclosporine—rheumatoid arthritis	0.00087	0.00206	CcSEcCtD
Loxapine—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.000868	0.00205	CcSEcCtD
Loxapine—Weight increased—Prednisone—rheumatoid arthritis	0.000867	0.00205	CcSEcCtD
Loxapine—Hypertension—Cyclosporine—rheumatoid arthritis	0.000866	0.00205	CcSEcCtD
Loxapine—Weight decreased—Prednisone—rheumatoid arthritis	0.000862	0.00204	CcSEcCtD
Loxapine—Vision blurred—Prednisolone—rheumatoid arthritis	0.000861	0.00203	CcSEcCtD
Loxapine—Chest pain—Cyclosporine—rheumatoid arthritis	0.000854	0.00202	CcSEcCtD
Loxapine—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000836	0.00198	CcSEcCtD
Loxapine—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000828	0.00196	CcSEcCtD
Loxapine—Confusional state—Cyclosporine—rheumatoid arthritis	0.000826	0.00195	CcSEcCtD
Loxapine—Dysgeusia—Triamcinolone—rheumatoid arthritis	0.000822	0.00194	CcSEcCtD
Loxapine—Oedema—Cyclosporine—rheumatoid arthritis	0.000819	0.00194	CcSEcCtD
Loxapine—Syncope—Prednisolone—rheumatoid arthritis	0.000819	0.00194	CcSEcCtD
Loxapine—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000803	0.0019	CcSEcCtD
Loxapine—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.000803	0.0019	CcSEcCtD
Loxapine—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000802	0.0019	CcSEcCtD
Loxapine—Syncope—Hydrocortisone—rheumatoid arthritis	0.0008	0.00189	CcSEcCtD
Loxapine—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000794	0.00188	CcSEcCtD
Loxapine—Angiopathy—Betamethasone—rheumatoid arthritis	0.000794	0.00188	CcSEcCtD
Loxapine—Convulsion—Prednisolone—rheumatoid arthritis	0.000791	0.00187	CcSEcCtD
Loxapine—Hypertension—Prednisolone—rheumatoid arthritis	0.000788	0.00186	CcSEcCtD
Loxapine—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.000784	0.00185	CcSEcCtD
Loxapine—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000782	0.00185	CcSEcCtD
Loxapine—Alopecia—Dexamethasone—rheumatoid arthritis	0.000774	0.00183	CcSEcCtD
Loxapine—Alopecia—Betamethasone—rheumatoid arthritis	0.000774	0.00183	CcSEcCtD
Loxapine—Convulsion—Hydrocortisone—rheumatoid arthritis	0.000773	0.00183	CcSEcCtD
Loxapine—Hypertension—Hydrocortisone—rheumatoid arthritis	0.00077	0.00182	CcSEcCtD
Loxapine—Asthenia—Leflunomide—rheumatoid arthritis	0.000761	0.0018	CcSEcCtD
Loxapine—Syncope—Triamcinolone—rheumatoid arthritis	0.000753	0.00178	CcSEcCtD
Loxapine—Syncope—Methylprednisolone—rheumatoid arthritis	0.000751	0.00178	CcSEcCtD
Loxapine—Pruritus—Leflunomide—rheumatoid arthritis	0.000751	0.00177	CcSEcCtD
Loxapine—Oedema—Prednisolone—rheumatoid arthritis	0.000745	0.00176	CcSEcCtD
Loxapine—Dizziness—Azathioprine—rheumatoid arthritis	0.000743	0.00176	CcSEcCtD
Loxapine—Insomnia—Cyclosporine—rheumatoid arthritis	0.000741	0.00175	CcSEcCtD
Loxapine—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.000738	0.00174	CcSEcCtD
Loxapine—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.000736	0.00174	CcSEcCtD
Loxapine—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000735	0.00174	CcSEcCtD
Loxapine—Shock—Prednisolone—rheumatoid arthritis	0.000733	0.00173	CcSEcCtD
Loxapine—Cough—Triamcinolone—rheumatoid arthritis	0.000733	0.00173	CcSEcCtD
Loxapine—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.00073	0.00173	CcSEcCtD
Loxapine—Somnolence—Cyclosporine—rheumatoid arthritis	0.000728	0.00172	CcSEcCtD
Loxapine—Oedema—Hydrocortisone—rheumatoid arthritis	0.000728	0.00172	CcSEcCtD
Loxapine—Convulsion—Triamcinolone—rheumatoid arthritis	0.000728	0.00172	CcSEcCtD
Loxapine—Tachycardia—Prednisolone—rheumatoid arthritis	0.000727	0.00172	CcSEcCtD
Loxapine—Photosensitivity reaction—Methotrexate—rheumatoid arthritis	0.000727	0.00172	CcSEcCtD
Loxapine—Convulsion—Methylprednisolone—rheumatoid arthritis	0.000726	0.00172	CcSEcCtD
Loxapine—Hypertension—Triamcinolone—rheumatoid arthritis	0.000725	0.00171	CcSEcCtD
Loxapine—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000723	0.00171	CcSEcCtD
Loxapine—Shock—Hydrocortisone—rheumatoid arthritis	0.000716	0.00169	CcSEcCtD
Loxapine—Vomiting—Azathioprine—rheumatoid arthritis	0.000715	0.00169	CcSEcCtD
Loxapine—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000714	0.00169	CcSEcCtD
Loxapine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.00071	0.00168	CcSEcCtD
Loxapine—Drowsiness—Methotrexate—rheumatoid arthritis	0.00071	0.00168	CcSEcCtD
Loxapine—Rash—Azathioprine—rheumatoid arthritis	0.000709	0.00167	CcSEcCtD
Loxapine—Dermatitis—Azathioprine—rheumatoid arthritis	0.000708	0.00167	CcSEcCtD
Loxapine—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000707	0.00167	CcSEcCtD
Loxapine—Fatigue—Cyclosporine—rheumatoid arthritis	0.000706	0.00167	CcSEcCtD
Loxapine—Headache—Azathioprine—rheumatoid arthritis	0.000704	0.00166	CcSEcCtD
Loxapine—Dizziness—Leflunomide—rheumatoid arthritis	0.000702	0.00166	CcSEcCtD
Loxapine—Constipation—Cyclosporine—rheumatoid arthritis	0.0007	0.00166	CcSEcCtD
Loxapine—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000699	0.00165	CcSEcCtD
Loxapine—Renal failure—Methotrexate—rheumatoid arthritis	0.000698	0.00165	CcSEcCtD
Loxapine—Angiopathy—Prednisone—rheumatoid arthritis	0.000692	0.00163	CcSEcCtD
Loxapine—Confusional state—Methylprednisolone—rheumatoid arthritis	0.00069	0.00163	CcSEcCtD
Loxapine—Oedema—Triamcinolone—rheumatoid arthritis	0.000685	0.00162	CcSEcCtD
Loxapine—Syncope—Betamethasone—rheumatoid arthritis	0.000683	0.00162	CcSEcCtD
Loxapine—Syncope—Dexamethasone—rheumatoid arthritis	0.000683	0.00162	CcSEcCtD
Loxapine—Hypotension—Hydrocortisone—rheumatoid arthritis	0.00068	0.00161	CcSEcCtD
Loxapine—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000675	0.0016	CcSEcCtD
Loxapine—Vomiting—Leflunomide—rheumatoid arthritis	0.000675	0.0016	CcSEcCtD
Loxapine—Shock—Triamcinolone—rheumatoid arthritis	0.000674	0.00159	CcSEcCtD
Loxapine—Insomnia—Prednisolone—rheumatoid arthritis	0.000674	0.00159	CcSEcCtD
Loxapine—Alopecia—Prednisone—rheumatoid arthritis	0.000674	0.00159	CcSEcCtD
Loxapine—Shock—Methylprednisolone—rheumatoid arthritis	0.000673	0.00159	CcSEcCtD
Loxapine—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000671	0.00159	CcSEcCtD
Loxapine—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.00067	0.00158	CcSEcCtD
Loxapine—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.00067	0.00158	CcSEcCtD
Loxapine—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000669	0.00158	CcSEcCtD
Loxapine—Rash—Leflunomide—rheumatoid arthritis	0.000669	0.00158	CcSEcCtD
Loxapine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000669	0.00158	CcSEcCtD
Loxapine—Dermatitis—Leflunomide—rheumatoid arthritis	0.000669	0.00158	CcSEcCtD
Loxapine—Nausea—Azathioprine—rheumatoid arthritis	0.000668	0.00158	CcSEcCtD
Loxapine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000667	0.00158	CcSEcCtD
Loxapine—Headache—Leflunomide—rheumatoid arthritis	0.000665	0.00157	CcSEcCtD
Loxapine—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.000662	0.00157	CcSEcCtD
Loxapine—Convulsion—Dexamethasone—rheumatoid arthritis	0.00066	0.00156	CcSEcCtD
Loxapine—Convulsion—Betamethasone—rheumatoid arthritis	0.00066	0.00156	CcSEcCtD
Loxapine—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000658	0.00156	CcSEcCtD
Loxapine—Hypertension—Dexamethasone—rheumatoid arthritis	0.000658	0.00156	CcSEcCtD
Loxapine—Hypertension—Betamethasone—rheumatoid arthritis	0.000658	0.00156	CcSEcCtD
Loxapine—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000654	0.00155	CcSEcCtD
Loxapine—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000639	0.00151	CcSEcCtD
Loxapine—Hepatitis—Methotrexate—rheumatoid arthritis	0.000637	0.00151	CcSEcCtD
Loxapine—Nausea—Leflunomide—rheumatoid arthritis	0.00063	0.00149	CcSEcCtD
Loxapine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000628	0.00149	CcSEcCtD
Loxapine—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000628	0.00148	CcSEcCtD
Loxapine—Vision blurred—Prednisone—rheumatoid arthritis	0.000625	0.00148	CcSEcCtD
Loxapine—Oedema—Betamethasone—rheumatoid arthritis	0.000622	0.00147	CcSEcCtD
Loxapine—Oedema—Dexamethasone—rheumatoid arthritis	0.000622	0.00147	CcSEcCtD
Loxapine—Insomnia—Triamcinolone—rheumatoid arthritis	0.00062	0.00147	CcSEcCtD
Loxapine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000619	0.00146	CcSEcCtD
Loxapine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000615	0.00145	CcSEcCtD
Loxapine—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000614	0.00145	CcSEcCtD
Loxapine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000614	0.00145	CcSEcCtD
Loxapine—Shock—Betamethasone—rheumatoid arthritis	0.000612	0.00145	CcSEcCtD
Loxapine—Shock—Dexamethasone—rheumatoid arthritis	0.000612	0.00145	CcSEcCtD
Loxapine—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000611	0.00144	CcSEcCtD
Loxapine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00061	0.00144	CcSEcCtD
Loxapine—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00061	0.00144	CcSEcCtD
Loxapine—Agitation—Prednisone—rheumatoid arthritis	0.00061	0.00144	CcSEcCtD
Loxapine—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000609	0.00144	CcSEcCtD
Loxapine—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000609	0.00144	CcSEcCtD
Loxapine—Tachycardia—Betamethasone—rheumatoid arthritis	0.000607	0.00143	CcSEcCtD
Loxapine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000607	0.00143	CcSEcCtD
Loxapine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000603	0.00143	CcSEcCtD
Loxapine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.0006	0.00142	CcSEcCtD
Loxapine—Syncope—Prednisone—rheumatoid arthritis	0.000595	0.00141	CcSEcCtD
Loxapine—Fatigue—Triamcinolone—rheumatoid arthritis	0.000591	0.0014	CcSEcCtD
Loxapine—Fatigue—Methylprednisolone—rheumatoid arthritis	0.00059	0.00139	CcSEcCtD
Loxapine—Asthenia—Cyclosporine—rheumatoid arthritis	0.000588	0.00139	CcSEcCtD
Loxapine—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000583	0.00138	CcSEcCtD
Loxapine—Hypotension—Dexamethasone—rheumatoid arthritis	0.000581	0.00137	CcSEcCtD
Loxapine—Hypotension—Betamethasone—rheumatoid arthritis	0.000581	0.00137	CcSEcCtD
Loxapine—Pruritus—Cyclosporine—rheumatoid arthritis	0.000579	0.00137	CcSEcCtD
Loxapine—Angiopathy—Methotrexate—rheumatoid arthritis	0.000578	0.00137	CcSEcCtD
Loxapine—Convulsion—Prednisone—rheumatoid arthritis	0.000575	0.00136	CcSEcCtD
Loxapine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000574	0.00136	CcSEcCtD
Loxapine—Hypertension—Prednisone—rheumatoid arthritis	0.000573	0.00135	CcSEcCtD
Loxapine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000565	0.00134	CcSEcCtD
Loxapine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000564	0.00133	CcSEcCtD
Loxapine—Alopecia—Methotrexate—rheumatoid arthritis	0.000563	0.00133	CcSEcCtD
Loxapine—Insomnia—Dexamethasone—rheumatoid arthritis	0.000562	0.00133	CcSEcCtD
Loxapine—Insomnia—Betamethasone—rheumatoid arthritis	0.000562	0.00133	CcSEcCtD
Loxapine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000558	0.00132	CcSEcCtD
Loxapine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000558	0.00132	CcSEcCtD
Loxapine—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000549	0.0013	CcSEcCtD
Loxapine—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000543	0.00128	CcSEcCtD
Loxapine—Dizziness—Cyclosporine—rheumatoid arthritis	0.000542	0.00128	CcSEcCtD
Loxapine—Oedema—Prednisone—rheumatoid arthritis	0.000542	0.00128	CcSEcCtD
Loxapine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000537	0.00127	CcSEcCtD
Loxapine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000537	0.00127	CcSEcCtD
Loxapine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000536	0.00127	CcSEcCtD
Loxapine—Fatigue—Betamethasone—rheumatoid arthritis	0.000536	0.00127	CcSEcCtD
Loxapine—Fatigue—Dexamethasone—rheumatoid arthritis	0.000536	0.00127	CcSEcCtD
Loxapine—Shock—Prednisone—rheumatoid arthritis	0.000533	0.00126	CcSEcCtD
Loxapine—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000531	0.00126	CcSEcCtD
Loxapine—Tachycardia—Prednisone—rheumatoid arthritis	0.000529	0.00125	CcSEcCtD
Loxapine—Vision blurred—Methotrexate—rheumatoid arthritis	0.000523	0.00124	CcSEcCtD
Loxapine—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000522	0.00123	CcSEcCtD
Loxapine—Vomiting—Cyclosporine—rheumatoid arthritis	0.000521	0.00123	CcSEcCtD
Loxapine—Rash—Cyclosporine—rheumatoid arthritis	0.000516	0.00122	CcSEcCtD
Loxapine—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000516	0.00122	CcSEcCtD
Loxapine—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000515	0.00122	CcSEcCtD
Loxapine—Headache—Cyclosporine—rheumatoid arthritis	0.000513	0.00121	CcSEcCtD
Loxapine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000512	0.00121	CcSEcCtD
Loxapine—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000512	0.00121	CcSEcCtD
Loxapine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000505	0.00119	CcSEcCtD
Loxapine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000504	0.00119	CcSEcCtD
Loxapine—Leukopenia—Methotrexate—rheumatoid arthritis	0.000496	0.00117	CcSEcCtD
Loxapine—Dizziness—Prednisolone—rheumatoid arthritis	0.000493	0.00117	CcSEcCtD
Loxapine—Asthenia—Triamcinolone—rheumatoid arthritis	0.000492	0.00116	CcSEcCtD
Loxapine—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000491	0.00116	CcSEcCtD
Loxapine—Insomnia—Prednisone—rheumatoid arthritis	0.00049	0.00116	CcSEcCtD
Loxapine—Nausea—Cyclosporine—rheumatoid arthritis	0.000486	0.00115	CcSEcCtD
Loxapine—Paraesthesia—Prednisone—rheumatoid arthritis	0.000486	0.00115	CcSEcCtD
Loxapine—Pruritus—Triamcinolone—rheumatoid arthritis	0.000485	0.00115	CcSEcCtD
Loxapine—Cough—Methotrexate—rheumatoid arthritis	0.000484	0.00114	CcSEcCtD
Loxapine—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000484	0.00114	CcSEcCtD
Loxapine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000481	0.00114	CcSEcCtD
Loxapine—Convulsion—Methotrexate—rheumatoid arthritis	0.000481	0.00114	CcSEcCtD
Loxapine—Chest pain—Methotrexate—rheumatoid arthritis	0.000472	0.00112	CcSEcCtD
Loxapine—Rash—Prednisolone—rheumatoid arthritis	0.00047	0.00111	CcSEcCtD
Loxapine—Dermatitis—Prednisolone—rheumatoid arthritis	0.000469	0.00111	CcSEcCtD
Loxapine—Fatigue—Prednisone—rheumatoid arthritis	0.000467	0.0011	CcSEcCtD
Loxapine—Headache—Prednisolone—rheumatoid arthritis	0.000467	0.0011	CcSEcCtD
Loxapine—Constipation—Prednisone—rheumatoid arthritis	0.000463	0.00109	CcSEcCtD
Loxapine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000463	0.00109	CcSEcCtD
Loxapine—Rash—Hydrocortisone—rheumatoid arthritis	0.000459	0.00108	CcSEcCtD
Loxapine—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000459	0.00108	CcSEcCtD
Loxapine—Confusional state—Methotrexate—rheumatoid arthritis	0.000456	0.00108	CcSEcCtD
Loxapine—Headache—Hydrocortisone—rheumatoid arthritis	0.000456	0.00108	CcSEcCtD
Loxapine—Dizziness—Triamcinolone—rheumatoid arthritis	0.000453	0.00107	CcSEcCtD
Loxapine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000452	0.00107	CcSEcCtD
Loxapine—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000446	0.00105	CcSEcCtD
Loxapine—Asthenia—Dexamethasone—rheumatoid arthritis	0.000446	0.00105	CcSEcCtD
Loxapine—Asthenia—Betamethasone—rheumatoid arthritis	0.000446	0.00105	CcSEcCtD
Loxapine—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000444	0.00105	CcSEcCtD
Loxapine—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000443	0.00105	CcSEcCtD
Loxapine—Nausea—Prednisolone—rheumatoid arthritis	0.000443	0.00105	CcSEcCtD
Loxapine—Pruritus—Betamethasone—rheumatoid arthritis	0.00044	0.00104	CcSEcCtD
Loxapine—Pruritus—Dexamethasone—rheumatoid arthritis	0.00044	0.00104	CcSEcCtD
Loxapine—Vomiting—Triamcinolone—rheumatoid arthritis	0.000436	0.00103	CcSEcCtD
Loxapine—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000435	0.00103	CcSEcCtD
Loxapine—Nausea—Hydrocortisone—rheumatoid arthritis	0.000432	0.00102	CcSEcCtD
Loxapine—Rash—Triamcinolone—rheumatoid arthritis	0.000432	0.00102	CcSEcCtD
Loxapine—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000432	0.00102	CcSEcCtD
Loxapine—Rash—Methylprednisolone—rheumatoid arthritis	0.000431	0.00102	CcSEcCtD
Loxapine—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000431	0.00102	CcSEcCtD
Loxapine—Headache—Triamcinolone—rheumatoid arthritis	0.000429	0.00101	CcSEcCtD
Loxapine—Headache—Methylprednisolone—rheumatoid arthritis	0.000428	0.00101	CcSEcCtD
Loxapine—Hypotension—Methotrexate—rheumatoid arthritis	0.000423	0.001	CcSEcCtD
Loxapine—Dizziness—Dexamethasone—rheumatoid arthritis	0.000411	0.000972	CcSEcCtD
Loxapine—Dizziness—Betamethasone—rheumatoid arthritis	0.000411	0.000972	CcSEcCtD
Loxapine—Insomnia—Methotrexate—rheumatoid arthritis	0.000409	0.000968	CcSEcCtD
Loxapine—Nausea—Triamcinolone—rheumatoid arthritis	0.000407	0.000962	CcSEcCtD
Loxapine—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000406	0.000961	CcSEcCtD
Loxapine—Nausea—Methylprednisolone—rheumatoid arthritis	0.000406	0.00096	CcSEcCtD
Loxapine—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000404	0.000954	CcSEcCtD
Loxapine—Somnolence—Methotrexate—rheumatoid arthritis	0.000402	0.000951	CcSEcCtD
Loxapine—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000399	0.000943	CcSEcCtD
Loxapine—Vomiting—Betamethasone—rheumatoid arthritis	0.000395	0.000935	CcSEcCtD
Loxapine—Vomiting—Dexamethasone—rheumatoid arthritis	0.000395	0.000935	CcSEcCtD
Loxapine—Rash—Dexamethasone—rheumatoid arthritis	0.000392	0.000927	CcSEcCtD
Loxapine—Rash—Betamethasone—rheumatoid arthritis	0.000392	0.000927	CcSEcCtD
Loxapine—Dermatitis—Betamethasone—rheumatoid arthritis	0.000392	0.000926	CcSEcCtD
Loxapine—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000392	0.000926	CcSEcCtD
Loxapine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000391	0.000924	CcSEcCtD
Loxapine—Fatigue—Methotrexate—rheumatoid arthritis	0.00039	0.000922	CcSEcCtD
Loxapine—Headache—Dexamethasone—rheumatoid arthritis	0.00039	0.000921	CcSEcCtD
Loxapine—Headache—Betamethasone—rheumatoid arthritis	0.00039	0.000921	CcSEcCtD
Loxapine—Asthenia—Prednisone—rheumatoid arthritis	0.000389	0.000919	CcSEcCtD
Loxapine—Pruritus—Prednisone—rheumatoid arthritis	0.000383	0.000906	CcSEcCtD
Loxapine—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000373	0.000882	CcSEcCtD
Loxapine—Nausea—Betamethasone—rheumatoid arthritis	0.000369	0.000873	CcSEcCtD
Loxapine—Nausea—Dexamethasone—rheumatoid arthritis	0.000369	0.000873	CcSEcCtD
Loxapine—Dizziness—Prednisone—rheumatoid arthritis	0.000358	0.000847	CcSEcCtD
Loxapine—Vomiting—Prednisone—rheumatoid arthritis	0.000344	0.000814	CcSEcCtD
Loxapine—Rash—Prednisone—rheumatoid arthritis	0.000341	0.000807	CcSEcCtD
Loxapine—Dermatitis—Prednisone—rheumatoid arthritis	0.000341	0.000806	CcSEcCtD
Loxapine—Headache—Prednisone—rheumatoid arthritis	0.000339	0.000802	CcSEcCtD
Loxapine—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000333	0.000788	CcSEcCtD
Loxapine—Asthenia—Methotrexate—rheumatoid arthritis	0.000325	0.000768	CcSEcCtD
Loxapine—Nausea—Prednisone—rheumatoid arthritis	0.000322	0.00076	CcSEcCtD
Loxapine—Pruritus—Methotrexate—rheumatoid arthritis	0.00032	0.000757	CcSEcCtD
Loxapine—Dizziness—Methotrexate—rheumatoid arthritis	0.000299	0.000708	CcSEcCtD
Loxapine—Vomiting—Methotrexate—rheumatoid arthritis	0.000288	0.00068	CcSEcCtD
Loxapine—Rash—Methotrexate—rheumatoid arthritis	0.000285	0.000675	CcSEcCtD
Loxapine—Dermatitis—Methotrexate—rheumatoid arthritis	0.000285	0.000674	CcSEcCtD
Loxapine—Headache—Methotrexate—rheumatoid arthritis	0.000284	0.00067	CcSEcCtD
Loxapine—Nausea—Methotrexate—rheumatoid arthritis	0.000269	0.000636	CcSEcCtD
Loxapine—CHRM4—Signaling Pathways—NFKB1—rheumatoid arthritis	1.49e-05	2.59e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MAPK8—rheumatoid arthritis	1.49e-05	2.58e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	1.49e-05	2.58e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	1.48e-05	2.56e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.47e-05	2.55e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MAPK8—rheumatoid arthritis	1.47e-05	2.55e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.46e-05	2.54e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	1.46e-05	2.53e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—POMC—rheumatoid arthritis	1.46e-05	2.53e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	1.46e-05	2.52e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.46e-05	2.52e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—IL6—rheumatoid arthritis	1.46e-05	2.52e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.46e-05	2.52e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	1.46e-05	2.52e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	1.46e-05	2.52e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ALB—rheumatoid arthritis	1.45e-05	2.52e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	1.45e-05	2.51e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	1.45e-05	2.51e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	1.45e-05	2.51e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	1.45e-05	2.51e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—rheumatoid arthritis	1.44e-05	2.49e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	1.44e-05	2.49e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	1.44e-05	2.49e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—rheumatoid arthritis	1.44e-05	2.49e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	1.43e-05	2.48e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.43e-05	2.47e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	1.43e-05	2.47e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	1.42e-05	2.47e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	1.42e-05	2.47e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	1.42e-05	2.46e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	1.42e-05	2.46e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—rheumatoid arthritis	1.42e-05	2.45e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	1.42e-05	2.45e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—rheumatoid arthritis	1.41e-05	2.44e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	1.41e-05	2.44e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	1.41e-05	2.44e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	1.41e-05	2.44e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	1.4e-05	2.43e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	1.4e-05	2.43e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	1.4e-05	2.43e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	1.4e-05	2.42e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.4e-05	2.42e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	1.39e-05	2.41e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	1.38e-05	2.4e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	1.38e-05	2.39e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—rheumatoid arthritis	1.37e-05	2.38e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.37e-05	2.37e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.36e-05	2.36e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	1.36e-05	2.36e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.36e-05	2.35e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—rheumatoid arthritis	1.36e-05	2.35e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.35e-05	2.33e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.34e-05	2.32e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	1.33e-05	2.31e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.32e-05	2.29e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	1.32e-05	2.29e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TGFB1—rheumatoid arthritis	1.32e-05	2.29e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TGFB1—rheumatoid arthritis	1.32e-05	2.28e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.31e-05	2.27e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	1.31e-05	2.27e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL2—rheumatoid arthritis	1.31e-05	2.27e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.3e-05	2.26e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—IL6—rheumatoid arthritis	1.3e-05	2.26e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.3e-05	2.26e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IL6—rheumatoid arthritis	1.3e-05	2.25e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	1.29e-05	2.24e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	1.29e-05	2.24e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	1.29e-05	2.23e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IL6—rheumatoid arthritis	1.29e-05	2.23e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.28e-05	2.22e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	1.28e-05	2.21e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.28e-05	2.21e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	1.27e-05	2.21e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	1.27e-05	2.21e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	1.27e-05	2.2e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	1.27e-05	2.2e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.27e-05	2.2e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	1.27e-05	2.19e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—rheumatoid arthritis	1.26e-05	2.19e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	1.25e-05	2.17e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	1.25e-05	2.17e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	1.25e-05	2.17e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.25e-05	2.16e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.25e-05	2.16e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.25e-05	2.16e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—rheumatoid arthritis	1.24e-05	2.16e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.24e-05	2.15e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—rheumatoid arthritis	1.24e-05	2.15e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.24e-05	2.14e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	1.23e-05	2.13e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.23e-05	2.12e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.22e-05	2.12e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.21e-05	2.11e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	1.21e-05	2.1e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.21e-05	2.09e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.2e-05	2.09e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.19e-05	2.07e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	1.19e-05	2.07e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.19e-05	2.07e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	1.19e-05	2.06e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.19e-05	2.05e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.18e-05	2.05e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.18e-05	2.04e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.17e-05	2.03e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.17e-05	2.02e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.16e-05	2.01e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.15e-05	2e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.15e-05	1.99e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.15e-05	1.99e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.15e-05	1.99e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.14e-05	1.97e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.13e-05	1.97e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.13e-05	1.96e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.13e-05	1.96e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	1.13e-05	1.96e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.13e-05	1.95e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	1.12e-05	1.95e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.12e-05	1.94e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.12e-05	1.94e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.12e-05	1.93e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.11e-05	1.93e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.11e-05	1.93e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.11e-05	1.92e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.1e-05	1.91e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	1.1e-05	1.91e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.1e-05	1.9e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	1.09e-05	1.9e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—rheumatoid arthritis	1.09e-05	1.88e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—rheumatoid arthritis	1.09e-05	1.88e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	1.08e-05	1.87e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	1.08e-05	1.87e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	1.08e-05	1.87e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.08e-05	1.87e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	1.08e-05	1.86e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	1.07e-05	1.86e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	1.07e-05	1.86e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	1.07e-05	1.86e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	1.07e-05	1.85e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.06e-05	1.84e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	1.06e-05	1.84e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	1.06e-05	1.84e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.06e-05	1.83e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	1.06e-05	1.83e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—rheumatoid arthritis	1.06e-05	1.83e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.05e-05	1.83e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	1.04e-05	1.8e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—rheumatoid arthritis	1.04e-05	1.8e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.03e-05	1.78e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.03e-05	1.78e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.03e-05	1.78e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—rheumatoid arthritis	1.02e-05	1.78e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	1.02e-05	1.77e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	1.02e-05	1.77e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.02e-05	1.77e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	1.02e-05	1.76e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	1.02e-05	1.76e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.01e-05	1.76e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.01e-05	1.76e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.01e-05	1.75e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.01e-05	1.75e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.01e-05	1.75e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.01e-05	1.75e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	1.01e-05	1.74e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	1e-05	1.74e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	1e-05	1.74e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	9.96e-06	1.73e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	9.95e-06	1.72e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—rheumatoid arthritis	9.94e-06	1.72e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	9.94e-06	1.72e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—rheumatoid arthritis	9.93e-06	1.72e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	9.92e-06	1.72e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	9.9e-06	1.72e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	9.87e-06	1.71e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	9.87e-06	1.71e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	9.84e-06	1.71e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	9.81e-06	1.7e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	9.79e-06	1.7e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	9.78e-06	1.69e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	9.77e-06	1.69e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	9.75e-06	1.69e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	9.72e-06	1.68e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—rheumatoid arthritis	9.66e-06	1.67e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—rheumatoid arthritis	9.51e-06	1.65e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	9.45e-06	1.64e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—rheumatoid arthritis	9.38e-06	1.63e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	9.35e-06	1.62e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	9.34e-06	1.62e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	9.31e-06	1.61e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	9.3e-06	1.61e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	9.23e-06	1.6e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	9.22e-06	1.6e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	9.19e-06	1.59e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	9.17e-06	1.59e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	9.14e-06	1.58e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	9.11e-06	1.58e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	9.06e-06	1.57e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	9.03e-06	1.56e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	9e-06	1.56e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	8.98e-06	1.56e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	8.58e-06	1.49e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	8.56e-06	1.48e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	8.44e-06	1.46e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	8.44e-06	1.46e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	8.42e-06	1.46e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—rheumatoid arthritis	8.41e-06	1.46e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	8.39e-06	1.45e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	8.37e-06	1.45e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	8.36e-06	1.45e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	8.33e-06	1.44e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	8.28e-06	1.44e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	8.26e-06	1.43e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	8.04e-06	1.39e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	8e-06	1.39e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	7.78e-06	1.35e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—rheumatoid arthritis	7.69e-06	1.33e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.68e-06	1.33e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	7.66e-06	1.33e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	7.62e-06	1.32e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	7.36e-06	1.28e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	7.32e-06	1.27e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	7.12e-06	1.23e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	7.06e-06	1.22e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	7.01e-06	1.21e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	6.95e-06	1.2e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	6.93e-06	1.2e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	6.91e-06	1.2e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	6.89e-06	1.19e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	6.82e-06	1.18e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	6.8e-06	1.18e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	6.46e-06	1.12e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	6.36e-06	1.1e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	6.34e-06	1.1e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	6.32e-06	1.1e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	6.32e-06	1.1e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	6.3e-06	1.09e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	6.24e-06	1.08e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	6.23e-06	1.08e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	5.78e-06	1e-05	CbGpPWpGaD
